kabutan

Renascience Inc.(4889) Summary

4889
TSE Growth
Renascience Inc.
1,730
JPY
0
(0.00%)
Dec 12, 3:30 pm JST
11.10
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
1,718
Dec 12, 11:32 pm JST
Summary Chart Historical News Financial Result
PER
PBR
14.0
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
1,726 JPY 11.09 USD
Previous Close Dec 11
1,730 JPY 11.08 USD
High Dec 12, 9:00 am
1,751 JPY 11.26 USD
Low Dec 12, 2:54 pm
1,711 JPY 10.98 USD
Volume
151,700
Trading Value
0.26B JPY 1.68M USD
VWAP
1728.15 JPY 11.09 USD
Minimum Trading Value
173,000 JPY 1,110 USD
Market Cap
0.02T JPY 0.14B USD
Number of Trades
709
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
High
1-Year Average
4,926
1-Year High May 21, 2025
38,929
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 0 1,531,200
Nov 28, 2025 400 1,429,500 3573.75
Nov 21, 2025 0 1,458,300
Nov 14, 2025 0 1,507,100
Nov 7, 2025 0 1,470,200
Company Profile
Renascience Inc. is a drug discovery venture originating from Tohoku University. The company focuses on developing therapeutic drugs using small molecule compounds and leverages AI for medical solutions.
Sector
Pharmaceuticals
Renascience Inc., a drug discovery venture born out of Tohoku University, is advancing the development of therapeutic drugs using small molecule compounds, with a focus on PAI-1 inhibitors. The company conducts clinical development in areas related to aging and lifestyle-associated diseases, including cancer, respiratory diseases, and mental disorders, and has a strong track record in physician-led clinical trials. Renascience Inc. is also committed to developing AI-powered medical devices, with pipelines in pulmonary function test diagnostics, maintenance hemodialysis support, and diabetes treatment assistance. The company emphasizes collaborative research with universities and medical institutions, having established an open innovation laboratory. With an integrated research and development system spanning from basic research to clinical development, Renascience Inc. aims to create medical innovations.